II 115th CONGRESS 1st Session S. 124 IN THE SENATE OF THE UNITED STATES January 12, 2017 Ms. Klobuchar (for herself and Mr. Grassley ) introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.